Last updated on April 2019

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy


Brief description of study

This is a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 2 study of DSP-7888 Dosing Emulsion plus Bevacizumab versus Bevacizumab alone in patients with recurrent or progressive glioblastoma multiforme (GBM) following treatment with first line therapy consisting of surgery and radiation with or without chemotherapy.

Clinical Study Identifier: NCT03149003

Find a site near you

Start Over

Center for Neurosciences

Tucson, AZ United States
  Connect »

Abbott Northwestern Hospital

Minneapolis, MN United States
  Connect »

Sansum Clinic

Santa Barbara, CA United States
  Connect »

Baylor Scott and White

Dallas, TX United States
  Connect »

Rhode Island Hospital

Providence, RI United States
  Connect »

University of Minnesota

Minneapolis, MN United States
  Connect »

Swedish Medical Center

Seattle, WA United States
  Connect »

Highlands Oncology Group

Fayetteville, AR United States
  Connect »

John Wayne Cancer Institute

Santa Monica, CA United States
  Connect »

University of Toledo

Toledo, OH United States
  Connect »

Tufts Medical Center

Boston, MA United States
  Connect »

Renovatio Clinical

The Woodlands, TX United States
  Connect »

Norton Cancer Institute

Louisville, KY United States
  Connect »

Henry Ford Health System

Detroit, MI United States
  Connect »

Piedmont brain tumor center

Atlanta, GA United States
  Connect »

Gangnam Severance Hospital

Gangnam-gu, Korea, Republic of
  Connect »

Samsung Medical Center

Gangnam-gu, Korea, Republic of
  Connect »

Severance Hospital

Seodaemun-gu, Korea, Republic of
  Connect »

Asan Medical Center

Songpa-gu, Korea, Republic of
  Connect »

UCSD- Moores Cancer Center

La Jolla, CA United States
  Connect »

Cedars Sinai Medical Center

Los Angeles, CA United States
  Connect »

Houston Methodist

Houston, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.